Update on the role of eslicarbazepine acetate in the treatment of partial-onset epilepsy

Eslicarbazepine acetate (ESL) is a once daily new third generation antiepileptic drug that shares the basic chemical structure of carbamazepine and oxcarbazepine – a dibenzazepine nucleus with the 5-carboxamide substituent, but is structurally different at the 10,11-position. ESL is a pro-drug metab...

Descripción completa

Detalles Bibliográficos
Autores principales: Tambucci, Renato, Basti, Claudia, Maresca, Maria, Coppola, Giangennaro, Verrotti, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4889089/
https://www.ncbi.nlm.nih.gov/pubmed/27307737
http://dx.doi.org/10.2147/NDT.S86765

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4889089/
https://www.ncbi.nlm.nih.gov/pubmed/27307737
http://dx.doi.org/10.2147/NDT.S86765

Ejemplares similares